February 7, 2025 01:17 PM EST
Pharma
Manufacturing

Bel­gian reg­u­la­tor rec­om­mends block­ing In­di­an drug­mak­er's API pro­duc­tion

Anna Brown

News Reporter

In­di­an drug­mak­er Maith­ili Life Sci­ences has re­ceived a non-com­pli­ant re­port from the Brus­sels-based Fed­er­al Agency for Med­i­cines and Health Prod­ucts for 24 is­sues re­lat­ed to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

Up­dat­ed: Bay Area biotech VC to shut down 15 months af­ter launch, sources say, af­ter key in­vestor pulls out

Ma­jor FDA staff cuts would slow drug re­views, ex­perts say

Bain buys Mit­subishi Tan­abe Phar­ma in $3.3B bet on Japan

Roche heads to FDA with Gazy­va re­sults in a form of lu­pus

Sen­a­tors ask FDA to dig in­to 'mis­lead­ing' Su­per Bowl ad from Hims

Bris­tol My­ers prunes pipeline amid new round of cost cuts

A service from the Financial Times